Prescription Drug Regulation, Promotion, And Advocacy Has Gotten More Vexing In 2017
Health Affairs Blog - REMOVED,
Editor’s note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard…
Editor’s note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard…
I dislike end-of-year “best of” lists, especially the “breakthroughs” that imply scientific discoveries and medical advances…
By Ameet Sarpatwari and Aaron S. Kesselheim Each month, members of the Program On Regulation, Therapeutics, And Law (PORTAL…
The 2016 election is (thankfully) almost here, and as one biotech analyst noted this week, a possible Democratic victory is to…